Industry Briefs: Apr. 9, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: Apr. 9, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

American Regent has initiated a nationwide voluntary recall of cyanocobalamin injection, USP, 1000 mcg/mL, 1-mL vial, for the following lot numbers: 1662, 1679, and 1683, due to cracks in the vials. Read More

AnaptysBio has announced a partnership with Celgene to develop antibodies against multiple therapeutic targets. Read More

Haupt Pharma has launched cold-chain storage capabilities in Japan. Read More

MPI Research and has agreed to provide preclinical and clinical testing to Edge Therapeutics. Read More

Shimadzu Scientific Instruments and the University of Texas at Arlington have formed the Shimadzu Center for Advanced Analytical Chemistry. Read More

Spectrum Pharmaceuticals has agreed to acquire Allos Therapeutics. Read More

Univar has expanded its relationship with BASF Pharma by adding its Cognis Pharmaline range to its European pharmaceutical portfolio. Read More

People News

Bioanalytical Systems, Inc. (BASi) has named Jacqueline Lemke chief financial officer. Read More

Lonza has appointed Richard Ridinger as CEO. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here